Ex-Harvard professor and serial entrepreneur Omid Farokhzad jumps into the SPAC game with some industry insiders and a certain billionaire scientist
Omid Farokhzad is jumping into the SPAC game, and he’s going in with one of the most experienced teams we’ve seen in biotech — an unusual blend of financial and industry insiders, deep-pocket investors and a certain billionaire scientist who has played a longtime support role for his former student.
The former Harvard professor had been co-founder for a string of biotechs before deciding to devote himself to a new role as CEO of Seer —where the big idea these past 2 years-plus has been to shift away from genomics in favor of a a proteomics platform that is doing some population-wide explorations, building a mountain of data that can be probed with machine learning tech in search of insights into diseases that can be used to develop liquid biopsy products for early-stage diagnosis.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.